Healthcare -
Biotechnology - NASDAQ - US
$ 7.48
2.89 %
$ 511 M
Market Cap
-3.76
P/E
EYPT - STOCK-BASED COMPENSATION
Stock-based Compensation EYPT - EyePoint Pharmaceuticals, Inc.
12.1 M
LAST VALUE
27.24%
2 YEAR CAGR
24.90%
5 YEAR CAGR
23.93%
10 YEAR CAGR